Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Schedule of consolidated balance sheets Condensed Balance Sheet [Table Text Block] Warrants Weighted Average Exercise Price Warrants Weighted Average Exercise Price [Abstract] No definition available. Restricted cash Restricted Cash, Current Award Timing Predetermined Award Timing Predetermined [Flag] Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) Asset Class [Axis] Asset Class [Axis] Entity File Number Entity File Number Additional Paid-in Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Warrants outstanding, beginning balance (in dollars per share) Warrants outstanding, ending balance (in dollars per share) Warrants Outstanding Weighted Average Exercise Price Weighted average of number of warrants or rights outstanding. Leases [Abstract] Leases [Abstract] Recent accounting pronouncements – issued, not yet adopted New Accounting Pronouncements, Policy [Policy Text Block] Schedule of quantitative information related to related party balances and transactions Schedule of Related Party Transactions [Table Text Block] Increase/(Decrease) in Accounts payable Increase (Decrease) in Accounts Payable Members' contributions Proceeds From Members Contributions Contributions made by members. Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants outstanding, beginning balance (in shares) Warrants outstanding, ending balance(in shares) Number Outstanding (in shares) Class of Warrant or Right, Outstanding Basic earnings (loss) per common share (in dollars per share) Earnings Per Share, Basic Stock-based compensation Stock-based compensation expense Stock-based compensation expense (income) Employee Benefit and Share-Based Payment Arrangement, Noncash Other Other Expenses Adjustment to Compensation: Adjustment to Compensation [Axis] Related Party Transactions Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounting Policies [Line Items] Accounting Policies [Line Items] Accounting Policies [Line Items] Revenue Revenue from Contract with Customer [Text Block] Accrued medical claims Medical Insurance Claim Liabilities, Current Amount of medical insurance claim liabilities, due within one year of the normal operating cycle, if longer. Medical supplies Medical supplies Supplies Expense Award Date [Axis] Award Date [Axis] Asset acquisition, distributable of cash paid Asset Acquisition, Distributable Of Cash Paid Asset Acquisition, Distributable Of Cash Paid Stock, Class of Stock [Table] Stock, Class of Stock [Table] Schedule of segment information Schedule of Segment Reporting Information, by Segment [Table Text Block] Common stock issued for Employee Stock Purchase Plan (in shares) Common stock issued for employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Adjustment to Compensation, Amount Adjustment to Compensation Amount Life insurance assumed ratio Life Insurance Assumed Ratio Employee Stock Option Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Term loans of Real Estate VIEs Term Loan 3 [Member] Represent the information pertaining to term loans of consolidated Real Estate Entities. Nutex Health Inc. equity Equity Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Year-to-date 2026 Compensation Expense Share-Based Payment Arrangement, Expense Schedule of property and equipment Property, Plant and Equipment [Table Text Block] Common stock authorized (in shares) Common Stock, Shares Authorized Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Current assets: Assets, Current [Abstract] Total liabilities and equity Liabilities and Equity Increase/(Decrease) in Accrued expenses and other current liabilities Increase (Decrease) in Other Current Liabilities Warrant issued (in dollars per share) Class Of Warrant Or Right, Warrants Issued, Weighted Average Issued Price Weighted average price of warrant issued when converting their warrants into shares. Liabilities and Equity Liabilities and Equity [Abstract] Cover [Abstract] Cover [Abstract] Maximum Maximum [Member] Weighted Average Useful Life (in years) Finite-Lived Intangible Asset, Useful Life Less: net income attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Total capital expenditures Segment, Expenditure, Addition to Long-Lived Assets Accounting Policies [Abstract] Accounting Policies [Abstract] Equity Incentive 2022 Plan Equity Incentive 2022 Plan [Member] Represent the information pertaining to Equity Incentive 2022 Plan. Total amortizing intangible assets Finite-Lived Intangible Assets, Net Acquisitions Asset Acquisition [Text Block] Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument Debt Instrument [Line Items] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Schedule of share-based payment arrangement, restricted stock and restricted stock unit, activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Share Repurchase Program [Line Items] Share Repurchase Program [Line Items] Common Stock Warrants Common Stock Warrants [Member] Represents information relating to common stock warrants. Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Nutex Health Inc Nutex Health Inc [Member] Information pertaining to Nutex Health Inc. Accrued wages and benefits Accrued Salaries, Current Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Income before taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Schedule of Long-Term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Accrued taxes other than income tax Accrual for Taxes Other than Income Taxes, Current Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Operating Segment Operating Segments [Member] Schedule of supplemental cash flows information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Warrants expired (in shares) Class Of Warrant Or Right, Warrants Expired Number of warrants expired. Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Current portion of long-term debt Less: current portion of long-term debt Long-Term Debt, Current Maturities Company Selected Measure Amount Company Selected Measure Amount Insurance Insurance [Member] Represent the information pertaining to insurance. Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Accrued expenses and other current liabilities Accrued Expenses And Other Liabilities, Current Accrued Expenses And Other Liabilities, Current Name Measure Name Real Estate VIEs Real Estate Variable Interest Entities [Member] Represent the information pertaining to real estate entities. Operating lease liabilities, current portion Operating Lease, Liability, Current Interest on lease liabilities Finance Lease, Interest Expense Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Term loans secured by all assets Term Loan [Member] Represent the information pertaining to term loans secured by assets. Class of Stock [Line Items] Class of Stock [Line Items] Deferred tax liabilities Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Increase/(Decrease) in Accrued income tax expense Increase (Decrease) in Accrued Taxes Payable Award Timing Method Award Timing Method [Text Block] Seller note Seller Note [Member] Seller Note Office furniture and equipment Furniture and Fixtures [Member] Award Type Award Type [Axis] Legal Entity [Axis] Legal Entity [Axis] Stock Split [Axis] Stock Split [Axis] Stock Split Total assets Total Assets Total assets Assets December 31, 2026 December 31, 2026 Measurement Period 1 [Member] December 31, 2026 Measurement Period 1 2027 Finite-Lived Intangible Asset, Expected Amortization, Year One Trading Symbol Trading Symbol Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Cash and cash equivalents and restricted cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Warrants expired (in dollars per share) Class Of Warrant Or Right, Warrants Expired Weighted Average Exercise Price Weighted average price of warrants expired. Schedule of detail of intangible assets Schedule of Intangible Assets and Goodwill [Table Text Block] Total accrued expenses and other current liabilities Accrued Liabilities and Other Liabilities Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] December 31, 2029 December 31, 2029 Expiration Warrant [Member] Warrants that expire December 31, 2029. February 29, 2024 February 29, 2024 Measurement Period 1 [Member] February 29, 2024 Measurement Period 1 Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount RSUs Dilutive effect of unvested restricted stock Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] 2030 Finite-Lived Intangible Asset, Expected Amortization, Year Four Entity Emerging Growth Company Entity Emerging Growth Company IDR Vendor IDR Vendor [Member] IDR Vendor Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Real estate division Real Estate Division [Member] Represent the information pertaining to real estate division. Number of contract doctors Number Of Contract Doctors Number of contract doctors employed by the company. Repayments of lines of credit Repayments of Lines of Credit Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Less: unamortized issuance costs and discount Debt Issuance Costs, Net Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Gross Carrying Amount Indefinite-Lived Intangible Assets (Excluding Goodwill) Related Party Related Party [Member] Dilutive effect of contingently issuable shares (in shares) Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares Common stock outstanding (in shares) Common Stock, Shares, Outstanding Partner with physicians Number Of Physicians Partnered Number of physicians with whom the company has partnered. Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] Schedule of disaggregate revenue Disaggregation of Revenue [Table Text Block] ER Entities ER Entities [Member] Represents information relating to ER entities. Number of full time employees Entity Number of Employees Stock-based compensation (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Stock Split [Domain] Stock Split [Domain] Stock Split Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Thereafter Finite-Lived Intangible Assets Amortization Expense, After Year Four Finite-Lived Intangible Assets Amortization Expense, After Year Four Schedule of share repurchase program Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Measurement Period After Current Quarter End Measurement Period After Current Quarter End [Member] Measurement Period After Current Quarter End Accrued supplier expenses Supplier Expenses Liabilities, Current Amount of supplier expenses liabilities, due within one year of the normal operating cycle, if longer. Retained Earnings (Accumulated Deficit) Retained Earnings [Member] October 31, 2029 October 31, 2029 Expiration Warrant [Member] Warrants that expire October 31, 2029. Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Share-Based Payment Arrangement Rollforward Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents and restricted cash - beginning of period Cash and cash equivalents and restricted cash - end of period Cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax expense Income Tax Expense (Benefit) Increase/(Decrease) in Accrued arbitration expenses Increase (Decrease) Estimated Litigation Liability, Current The increase or decrease of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position. Accrued income tax expense Taxes Payable, Current Intangible assets, net Net Carrying Amount Intangible Assets, Net (Excluding Goodwill) Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Total cost Property, Plant and Equipment, Gross May 31, 2027 May 31, 2027 Expiration Warrant [Member] Warrants that expire May 31, 2027. Property, plant and equipment Property, Plant and Equipment [Member] Net income Net income (loss) Net income Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] (Increase)/Decrease in Operating right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Member relationships Member Relationships [Member] Represent the information pertaining to member relationships. Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Clinigence Holdings, Inc. Clinigence Holdings Inc. [Member] Represents information relating to Clinigence Holdings, Inc. Buildings and improvements Building and Building Improvements [Member] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Dilutive effect of common stock warrants (in shares) Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants RSUs Unvested Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right Class of Warrant or Right [Line Items] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative expenses General and Administrative Expense Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash provided by operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation November 30, 2026 November 30, 2026 Measurement Period 1 [Member] November 30, 2026 Measurement Period 1 Related Party Transactions [Abstract] Related Party Transactions [Abstract] Acquisition of financing leases Acquisition Of Financing Leases Amount of acquisition of financing leases. Useful Life (years) Property, Plant and Equipment, Useful Life Subsequent Event Subsequent Event [Member] Distributions Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders and Retained Earnings Decrease in noncontrolling interest and retained earning balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders. Goodwill, net Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount 2026 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Numerator: Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Equity Components [Axis] Equity Components [Axis] Property, Plant and Equipment Property, Plant and Equipment [Line Items] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Debt accretion expense Accretion Expense Number of reportable segments Number of Reportable Segments Organization and Operations Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Weighted Average Remaining Contractual Life (years) Warrants and Rights Outstanding, Term Variable Interest Entities Variable Interest Entity Disclosure [Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Summary of cash, cash equivalents and restricted cash Restrictions on Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province Repayments of finance leases Finance Lease, Principal Payments June 30, 2025 June 30, 2025 Measurement Period 1 [Member] June 30, 2025 Measurement Period 1 Related and Nonrelated Parties [Domain] Related and Nonrelated Parties [Domain] Total current liabilities Current liabilities Liabilities, Current Medical equipment Medical Equipment [Member] Represent the information pertaining to medical equipment. Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Excluding Exchange Rate Effect, Including Discontinued Operation Warrants exercised (in shares) Class Of Warrant Or Right, Warrants Exercised Number of warrants exercised during the period. Vesting of Restricted Stock Units (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Gross Individual: Individual [Axis] Restricted cash Restricted Cash Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Axis] Entity [Domain] Entity [Domain] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Cash paid for interest on long-term debt Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of presentation Basis of Accounting, Policy [Policy Text Block] Contract services Contract services Professional and Contract Services Expense Interim financial statements Interim Financial Statements Policy [Policy Text Block] Disclosure of accounting policy for interim financial statements. Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Effective tax rate (as a percent) Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Health Care Organization, Revenue Sources [Domain] Health Care Organization, Revenue Sources [Domain] Operating lease cost Operating Lease, Cost March 02 2026 Grant March 02 2026 Grant [Member] March 02 2026 Grant Plan Name [Domain] Plan Name [Domain] Accounting Policies [Table] Accounting Policies [Table] Accounting Policies Equity [Abstract] Equity [Abstract] Conversion ratio Merger Agreement Conversion Ratio Number of shares issuable upon merger for each share of stock held and to be converted. Segment Information Segment Reporting Disclosure [Text Block] IPAs AHPIPA [Member] Represent the information pertaining to AHPIPA. Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Deferred payment Payment Deferral [Member] Trademarks Trademarks [Member] Accrued stock-based compensation Deferred Compensation Share-Based Arrangements, Liability, Current Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Term loans secured by property and equipment Term Loan 1 [Member] Represent the information pertaining to term loans secured by property and equipment. Finite-Lived Intangible Assets Finite-Lived Intangible Assets [Line Items] Ownership [Domain] Ownership [Domain] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Amortization of intangible assets Amortization of Intangible Assets Restricted cash - beginning of period Restricted cash - end of period Restricted Cash and Cash Equivalent, Current Stock repurchased during period, value Stock Repurchased During Period, Value Depreciation and amortization Total depreciation and amortization Depreciation, Depletion and Amortization Other assets Other long-term assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key PEO Name PEO Name Total revenue Total revenue Revenues Percentage of the market value at which employee stock purchase plan participants are entitled to purchase stock under the plan Share Based Compensation Arrangement By Share Based Payment Award Employee Stock Purchase Plan Market Grant Price Percentage The percentage of the market value at which employee stock purchase plan participants are entitled to purchase stock under the plan. Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Supplemental Cash Flow Elements [Abstract] Supplemental Cash Flow Elements [Abstract] Dilutive effect of convertible note (in shares) Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Schedule of lease of property and equipment Property, Plant, and Equipment, Lessor Asset under Operating Lease [Table Text Block] Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Hospital division Hospital division revenue Hospital Division [Member] Information related to the hospital division. Segments [Axis] Segments [Axis] Exercise Price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Shares repurchased under the March 2026 Repurchase Program March 2026 Share Repurchase Program [Member] March 2026 Share Repurchase Program (Increase)/Decrease in Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Federal statutory rate (as a percent) Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Share price (in dollars per share) Share Price Subsequent Event Type Subsequent Event Type [Axis] June 16 2024 Grant June 16 2024 Grant [Member] June 16 2024 Grant Stock-based Compensation Share-Based Payment Arrangement [Text Block] Stock repurchases and retirements (in shares) Shares repurchased and retired (in shares) Number of shares retired (in shares) Stock Repurchased and Retired During Period, Shares Warrants exercised (in dollars per share) Class Of Warrant Or Right, Warrants Exercised, Weighted Average Exercise Price Weighted average price at which holders acquired shares when converting their warrants into shares. Schedule of measurement of shares issued Schedule of Measurement of Shares Issued [Table Text Block] Schedule of Measurement of Shares Issued Assets Assets [Abstract] Long-term debt, net Total long-term debt Long-Term Debt, Excluding Current Maturities Nonrelated Party Nonrelated Party [Member] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Three Debt Instrument [Axis] Debt Instrument [Axis] Forfeitures (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Gross Carrying Amount Finite-Lived Intangible Assets, Gross Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Aggregate Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Aggregate Grant Date Fair Value Non-current operating lease liabilities, net Operating Lease, Liability, Noncurrent Common stock issued for Employee Stock Purchase Plan Stock Issued Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract] November 30, 2029 November 30, 2029 Expiration Warrant [Member] Warrants that expire November 30, 2029. Ownership [Axis] Ownership [Axis] Schedule of outstanding warrants Schedule Of Outstanding Warrants [Table Text Block] Tabular disclosure of warrants outstanding. Stock-based compensation APIC, Share-Based Payment Arrangement, Recognition and Exercise Fair Value as of Grant Date Award Grant Date Fair Value Accounts receivable, related parties Accounts Receivable, after Allowance for Credit Loss Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Number of real estate entities consolidated Number Of Consolidated Real Estate Entities The number of real estate entities consolidated. Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Payroll Payroll Labor and Related Expense Dilutive effect of unvested restricted stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Total operating costs and expenses Costs and Expenses RSUs Forfeited Forfeitures (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Unrecognized compensation cost Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Related Party Transactions Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Measurement Period Prior To Current Quarter End Measurement Period Prior To Current Quarter End [Member] Measurement Period Prior To Current Quarter End Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Schedule of debt Schedule of Debt [Table Text Block] Schedule of accrued expenses and other current liabilities Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Physician LLCs Physician LLCs [Member] Represent the information pertaining to Physician LLC. Granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Axis] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Total operating costs and expenses Costs And Expenses, Before Depreciation, Depletion And Amortization Expense Costs And Expenses, Before Depreciation, Depletion And Amortization Expense Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Contributions Noncontrolling Interest, Increase from Subsidiary Equity Issuance Common stock issued for Employee Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Land Land [Member] Name Trading Arrangement, Individual Name All Award Types Award Type [Domain] Noncontrolling interests Equity, Attributable to Noncontrolling Interest Equity Awards Adjustments Equity Awards Adjustments [Member] Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Disaggregation of Revenue Disaggregation of Revenue [Line Items] September 30, 2029 September 30, 2029 Expiration Warrant [Member] Warrants that expire September 30, 2029 Compensation Amount Outstanding Recovery Compensation Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Certificates of Deposit Certificates of Deposit [Member] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Share Repurchase Program [Axis] Share Repurchase Program [Axis] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Accrued Expenses and Other Current Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Multiplying factor Multiplying Factor For Calculation Of Owners Pro Rata Share Of Common Stock The multiplying factor for calculation of owners pro rata share of common stock. Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Revenue: Revenues [Abstract] Stock retired, value, settlement of obligation Stock Retired, Value, Settlement Of Obligation Stock Retired, Value, Settlement Of Obligation Variable Interest Entities Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Segments [Domain] Segments [Domain] Award Measurement Period [Axis] Award Measurement Period [Axis] Award Measurement Period Award Date [Domain] Award Date [Domain] Performance Shares Performance Shares [Member] Remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Organization and Operations Organization and Operations [Abstract] n/a February 28, 2025 February 28, 2025 Measurement Period 1 [Member] February 28, 2025 Measurement Period 1 (Increase)/Decrease in Inventories Increase (Decrease) in Inventories Lines of credit Less: short-term lines of credit Line of Credit, Current Inventories Inventory, Net Cash paid for interest on finance leases Interest Paid, Finance Leases Amount of cash paid for interest, for finance leases. Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Merger Agreement Merger Agreement [Member] Information pertaining to mergers. Minimum Minimum [Member] Repayments of notes payable Repayments of Notes Payable Accumulated depreciation, depletion and amortization, property, plant, and equipment Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Company Selected Measure Name Company Selected Measure Name Physician LLC and Real Estate Entities Physician LLC and Real Estate Entities [Member] Represents information relating to Physician LLC and Real Estate Entities. IDR arbitration process Arbitration Process Duration Duration of arbitration process to receive payments. Debt Debt Disclosure [Text Block] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Schedule of assets Schedule of Impaired Intangible Assets [Table Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Net income (loss) attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted All Executive Categories All Executive Categories [Member] Common stock, $0.001 par value; 950,000,000 shares authorized; 6,951,622 and 5,511,452 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively Common Stock, Value, Issued Financing lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Weighted average shares used to compute diluted EPS (in shares) Weighted Average Number of Shares Outstanding, Diluted Segment reporting Segment Reporting, Policy [Policy Text Block] Commitments and contingencies (Note 10) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Prepaid expenses related to IDRE fees Prepaid Legal Fees Carrying amount of legal fees including arbitration and mediation proceedings as of the balance sheet date of expenditures made in advance of when the economic benefit of the cost will be realized, and which will be expensed in future periods with the passage of time or when a triggering event occurs. July 31, 2026 July 31, 2026 Expiration Warrant [Member] Warrants that expire July 31, 2026. Business Combination [Axis] Business Combination [Axis] March 10 2025 Grant March 10 2025 Grant [Member] March 10 2025 Grant Entity Small Business Entity Small Business Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Noncontrolling Interests Noncontrolling Interest [Member] March 31, 2026 March 31, 2026 Measurement Period 1 [Member] March 31, 2026 Measurement Period 1 Document Transition Report Document Transition Report August 31, 2025 August 31, 2025 Measurement Period 1 [Member] August 31, 2025 Measurement Period 1 Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Self pay Selfs Pay [Member] Represent the information pertaining to self pay. Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Income Taxes Income Tax Disclosure [Text Block] Proceeds from lines of credit Proceeds from Lines of Credit Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Scenario [Axis] Scenario [Axis] Increase/(Decrease) in Operating lease liabilities Increase (Decrease) in Operating Lease Liability Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Shares acquired, average cost (in dollars per share) Shares Acquired, Average Cost Per Share Document Type Document Type Earnings (Loss) per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Vendor [Domain] Vendor [Domain] Vendor [Domain] All Individuals All Individuals [Member] Acquisitions of property and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Common stock authorized (in shares) Share Repurchase Program, Authorized, Amount Indefinite-Lived Intangible Assets Indefinite-Lived Intangible Assets [Member] Vehicles Vehicles [Member] 2023 Employee Stock Purchase Plan Employee Stock Purchase Plan, 2023 [Member] Represents information relating to 2023 employee stock purchase plan. Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net income (loss) attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Percentage of pro-rata share Asset Acquisition, Percentage Of Pro-Rata Share Asset Acquisition, Percentage Of Pro-Rata Share Proceeds from notes payable Proceeds from Notes Payable Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Current liabilities: Liabilities, Current [Abstract] Total corporate and other costs Corporate and other costs Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Medicare/Medicaid Medicare [Member] Represent the information pertaining to medicare and medicaid. Beginning balance (in shares) End balance (in shares) Shares, Outstanding Related Party Transaction [Table] Related Party Transaction [Table] Diluted earnings (loss) per common share (in dollars per share) Earnings Per Share, Diluted Forecast Forecast [Member] Population health management division Population health management division revenue Population Health Management Division [Member] Information related to the population health management division. Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Prior to the reverse stock split Prior to Reverse Stock Split [Member] Represents information relating to prior to reverse stock split. Total finance lease cost Finance Lease, Cost Finance Lease, Cost Title of 12(b) Security Title of 12(b) Security July 14 2025 Grant July 14 2025 Grant [Member] July 14 2025 Grant Accounts payable, related parties Accounts Payable Earnings per common share: Earnings Per Share [Abstract] Consolidation Items [Domain] Consolidation Items [Domain] Ownership percentage Subsidiary, Ownership Percentage, Parent Members' distributions Repayments Of Members Distributions Distributions made to members. Nutex Subsidiaries Nutex Subsidiaries [Member] Represents information relating to Nutex subsidiaries. Schedule of allocation of the estimated transaction price Targeted or Tracking Stock [Table Text Block] Gross profit Gross Profit Stock repurchases and retirements Stock Repurchased and Retired During Period, Value Restricted short-term investments Restricted Investments, Current Cash paid for income taxes Income Taxes Paid, Net Computer hardware and software Computer Hardware And Software [Member] Represent the information pertaining to computer hardware and software. 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Two Award Timing Disclosures [Line Items] Total Long-Term Debt, Gross Property and Equipment, net Property, Plant and Equipment Disclosure [Text Block] Percentage of net patient service revenue Percentage of Net Patient Service Revenue Percentage of net patient service revenue paid by insurers, federal agencies and other non patient third parties. Equity Equity [Text Block] Interest Rates Debt Instrument, Interest Rate During Period Net income attributable to Nutex Health Inc. Net Income (Loss) Attributable to Parent Subsequent Event [Table] Subsequent Event [Table] Intersegment Eliminations Intersegment Eliminations [Member] Expiration Date Trading Arrangement Expiration Date Construction in progress Construction in Progress [Member] Accrued other Other Accrued Liabilities, Current Equity: Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Warrants Outstanding Warrants , Number Rollforward [Abstract] No definition available. Share-based award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Property and equipment, net (accumulated depreciation of 33,598 and 31,696 as of March 31, 2026 and December 31, 2025, respectively) Total property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Segment Information Segment Reporting Information [Line Items] Cash related to stock repurchases and retirements Payments for Repurchase of Common Stock Adoption Date Trading Arrangement Adoption Date Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] (Increase)/Decrease in Accounts receivable Increase (Decrease) in Accounts Receivable Share Repurchase Program Share Repurchase Program [Member] Share Repurchase Program Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Operating income Operating Income (Loss) Line of credit secured by all assets Line of Credit [Member] Consolidated Entities [Domain] Consolidated Entities [Domain] Shares repurchased under the August 2025 Repurchase Program August 2025 Share Repurchase Program [Member] August 2025 Share Repurchase Program Change in accrued stock based compensation Reversal Of Share Based Compensation Expense Amount of reversal of share based compensation expense during the period Accumulated deficit Retained Earnings (Accumulated Deficit) Schedule of activity related to repurchase and retirement of shares Class of Treasury Stock [Table Text Block] Nutex Health Holdco LLC Nutex Health Holdco LLC [Member] Represents information relating to Nutex Health Holdco LLC. Signage Signage [Member] Represent the information pertaining to signage. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Financing lease liabilities, current portion Finance Lease, Liability, Current Current Fiscal Year End Date Current Fiscal Year End Date Subsequent Event Type Subsequent Event Type [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Workers compensation Workers' Compensation Insurance [Member] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Award Measurement Period [Domain] Award Measurement Period [Domain] Award Measurement Period [Domain] Payables and Accruals [Abstract] Payables and Accruals [Abstract] Weighted Average Grant-Date Fair Value Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Other expense Other expense Other Nonoperating Income (Expense) Statement Statement [Table] Number Exercisable (in shares) Class of Warrant or Right, Exercisable Number of warrants or rights exercisable. Changes to deferred taxes Deferred Income Tax Expense (Benefit) Adjustment to reconcile net income to net cash from operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Warrants issued (in shares) Class Of Warrant Or Right, Warrants Issued Class Of Warrant Or Right, Warrants Issued Non-current financing lease liabilities, net Finance Lease, Liability, Noncurrent Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Number of hospital facilities Number of Hospital Facilities Operated Represents number of hospital facilities operated by the company. Leases Lessee, Operating Leases [Text Block] Termination Date Trading Arrangement Termination Date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Finance lease cost: Finance Lease Cost [Abstract] No definition required Schedule of common stock warrants Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Inception-to-date Compensation Expense Share-Based Payment Arrangement, Expense To Date Share-Based Payment Arrangement, Expense To Date Weighted average shares used to compute basic EPS (in shares) Weighted Average Number of Shares Outstanding, Basic Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Stock repurchase program, remaining authorized repurchase amount Share Repurchase Program, Remaining Authorized, Amount Supplemental Cash Flows Information Cash Flow, Supplemental Disclosures [Text Block] Scheduled of computation of earnings (loss) per basic and diluted share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Share Repurchase Program [Table] Share Repurchase Program [Table] Subsequent Events [Abstract] Subsequent Events [Abstract] Segment Reporting [Abstract] Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Scenario [Domain] Scenario [Domain] Operating costs and expenses: Costs and Expenses [Abstract] Cash paid for operating leases Operating Lease, Payments, Use Accrued arbitration expenses Estimated Litigation Liability, Current Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-Based Payment Arrangement Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Consolidated Entities [Axis] Consolidated Entities [Axis] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock issued (in shares) Common Stock, Shares, Issued February 28, 2023 February 28, 2023 Measurement Period 1 [Member] February 28, 2023 Measurement Period 1 Intangible Assets and Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Number of Shares Issued to Date (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Shares Issued To Date Share-Based Compensation Arrangement By Share-Based Payment Award, Shares Issued To Date Use of estimates Use of Estimates, Policy [Policy Text Block] Number of states the company operates within Number of States Locations Represents number of states the company operates within. Interest expense, net Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Lease income Operating Lease, Lease Income Subsequent Events Subsequent Events [Text Block] Insider Trading Arrangements [Line Items] Corporate non-segment reconciling item Segment Reporting, Reconciling Item, Corporate Nonsegment [Member] Security Exchange Name Security Exchange Name Shares retired under the Settlement Agreements with former doctor owners of under construction hospitals (in shares) Stock Retired, Shares, Settlement Of Obligation Stock Retired, Shares, Settlement Of Obligation Facility Entity Facility Entity [Member] Facility Entity Long-term liabilities Liabilities, Noncurrent Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Financed capital expenditures Capital Expenditures Incurred but Not yet Paid Outstanding obligations of contributions for facilities Contributions in Aid of Construction Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Share repurchases (in shares) Stock Repurchased During Period, Shares Corporate and other costs: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Asset Class [Domain] Asset Class [Domain] Vendor [Axis] Vendor [Axis] Vendor Statement Statement [Line Items] Consolidation Items [Axis] Consolidation Items [Axis] Lease obligation payments Payments for Leasing Costs Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and cash equivalents - beginning of the period Cash and cash equivalents - end of period Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Schedule of changes in restricted stock units Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Subsequent Event [Line Items] Subsequent Event [Line Items] Common Stock Common Stock [Member] RSUs Vested Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member]